InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (5 ops.)
Discover the complete record of transactions filed by Regan Barry J., Chief Operating Officer. Insider active across 1 companies, notably DEXCOM INC. Aggregated, 8 filings have been logged. Total volume traded: €2.7m. The latest transaction was filed on 29 March 2022 (Cession). Regulator: SEC (Form 4). All data is openly available.
Declarations8 total
€498,5791,106 shares@ €450.7950.0020% mcap18.8% of flow
Common Stock
SEC:0001093557-22-000078:0·
€54,984 shares@ €0.00090.0000% mcap0.0% of flow
Common Stock
SEC:0001093557-22-000052:0·
€11,671 shares@ €0.00090.0000% mcap0.0% of flow
Common Stock
SEC:0001093557-21-000286·
€11,671 shares@ €0.00090.0000% mcap0.0% of flow
Common Stock
SEC:0001093557-21-000286:0·
€605,2171,214 shares@ €498.5310.0024% mcap56.1% of flow
Common Stock
SEC:0001093557-21-000274·
€605,2171,214 shares@ €498.5310.0024% mcap22.8% of flow
Common Stock
SEC:0001093557-21-000274:0·
€474,071837 shares@ €566.39310.0019% mcap43.9% of flow
Common Stock
SEC:0001093557-21-000263·
€474,071837 shares@ €566.39310.0019% mcap17.8% of flow
Common Stock
SEC:0001093557-21-000263:0·
8 of 8 declarations
About Regan Barry J.
Barry J. Regan is the Executive Vice President of Operations at Dexcom Inc. As EVP, he is responsible for managing the company's global operations, specializing in glucose monitoring technologies. Dexcom Inc. is known for its innovations in healthcare. Regan plays a crucial role in optimizing operational processes and improving efficiency.
